Skip to content

Intermedics Model 430-07 Bipolar Implantable Endocardial Pacing Lead

by Intermedics, Inc. 510(k)

Active United States

510(k) K954719

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)ST Traditional NumberK954719 Date27 Feb 1996DecidedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
ST

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Intermedics Model 430-07 is a Permanent Pacemaker Electrode, classified under FDA regulation 870.3680. This bipolar endocardial pacing lead is designed to transmit electrical pacing stimuli from an implanted pulse generator to the heart, facilitating cardiac rhythm regulation. It incorporates a passive-fixation mechanism to secure placement within the endocardial tissue, ensuring stable pacing functionality over time.

The lead is supplied sterile and intended for single-use implantation in cardiac procedures. It features coradial individually coated conductor coils and a polyurethane insulation sheath for durability and biocompatibility. The device holds FDA 510(k) clearance (K954719) and is subject to traditional review under the Cardiovascular advisory committee. Storage requires adherence to manufacturer guidelines to maintain sterility and performance integrity.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Intermedics Model 430-07 Bipolar Implantable Endocardial Pacing Lead, and how does it function in the body?

    The Intermedics Model 430-07 is designed to transmit electrical pacing signals from an implanted pulse generator to the heart, helping regulate cardiac rhythm. It uses a bipolar electrode configuration and a passive-fixation mechanism to anchor securely within the endocardial tissue, ensuring stable pacing over time. This makes it ideal for patients requiring long-term cardiac rhythm support.

  • Is the Intermedics Model 430-07 intended for reuse, or is it meant for single-use implantation?

    The device is explicitly labeled as sterile and intended for single-use implantation in cardiac procedures. Reuse is not recommended, as it could compromise sterility and performance integrity, potentially leading to complications.

  • What materials are used in the construction of the Intermedics Model 430-07, and why are they significant?

    The lead features coradial individually coated conductor coils and a polyurethane insulation sheath, both chosen for durability and biocompatibility. The polyurethane sheath ensures long-term stability within the body, while the coated coils reduce the risk of corrosion or tissue irritation, critical for reliable pacing functionality.

  • How should the Intermedics Model 430-07 be stored to maintain its sterility and performance?

    Storage must follow the manufacturer’s guidelines to preserve sterility and performance. Since it is sterile upon packaging, it should remain unopened until use and stored in a clean, dry environment away from direct sunlight or extreme temperatures, as per standard medical device handling protocols.

  • What regulatory pathway was followed for FDA clearance of this device, and what does that mean for clinicians?

    The Intermedics Model 430-07 received FDA 510(k) clearance (K954719) under traditional review with the Cardiovascular Advisory Committee. This means it was deemed substantially equivalent to a legally marketed predicate device, ensuring it meets established safety and effectiveness standards for permanent pacemaker electrodes. Clinicians can rely on its compliance with FDA requirements for cardiovascular pacing leads.